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The monoclonal antibodies anti-2H4 and antL4B4 identify the suppres- 
sor-inducer (CD4+2H4+) and helper-inducer (CD4+4B4+) subpo- 
pulations of CD4 (T4-t) lymphocytes, respectively. The cell surface 
phenotype of peripheral blood lymphocytes and synovial fluid lympho- 
cytes in patients with rheumatoid arthritis and other inflammatory joint 
diseases was analyzed by use of these and other well-characterized 
anti-T-cell monoclonal antibodies. In the synovial fluid of patients with 
rheumatoid arthritis, there was a markedly decreased percentage of 
T4+2H4+ suppressor-inducer cells (3.1 f 1 percent) and an in- 
creased percentage of T4+484+ helper-inducer cells (29.1 f 9 
percent) as compared with the proportions found in the peripheral 
blood of normal individuals (T4-t2H4-F: 19.0 f 6 percent, T4+4B4-t: 
23.0 f 7 percent). Moreover, patients with other chronic and acute 
inflammatory joint diseases exhibited highly similar synovial T-cell 
findings to those of the patients with rheumatoid arthritis (T4+2H4+: 
4.2 f 3 percent, T4+484+: 33.1 f 9 percent). In contrast, there 
were no significant differences between the normal control subjects 
and patients with rheumatoid arthritis in the percentage of T4+2H4i- 
cells in peripheral blood lymphocytes, nor were there significant differ- 
ences between normal control subjects, patients with rheumatoid 
arthritis, and patients with other joint diseases (osteoarthritis, gout, 
B27-F spondyloarthropathy, and psoriatic arthritis) in the number of 
T4+4B4+ cells or in the T4/T8 ratio of peripheral blood lymphocytes. 
However, very low numbers of T4-F2H4-F (suppressor-inducer) pe- 
ripheral blood lymphocytes were seen in a subgroup of patients, 
including five of seven with Reiter’s syndrome and several patients with 
systemic rheumatic disease syndromes. In addition, although the per- 
centage of T4+2H4+ cells in peripheral blood lymphocytes of patients 
with osteoarthritis (13.7 f 7 percent) and gout (14.3 f 7 percent) 
was decreased compared with that of normal controls (19.0 f 6 
percent) (osteoarthritis versus normal controls p <0.025), this differ- 
ence appeared to reflect alterations due to age rather than disease. 
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were also functionally defe&e, since autologous mixed lymphocyte 
Consistent with the nhenotvoic char-roes observed, svnovial T cells 
reaction-activated T4 cells from the synovial fluid of patients with 
rheumatoid arthritis failed to exhibit suppressor-inducer activity. The 
results indicate that diminished proportions of CD4+2H4+ (suppres- 
sor-inducer) cells and increased nrooortions of CD4+4B4+ (helper) . . . . I 
cells are a common feature of CD4-F cells in synovial fluid in rheuma- 
toid arthritis as well as a variety of other inflammatory disorders, 
whereas modest changes in CD4+2H4+ peripheral blood lympho- 
cytes are seen in older individuals and more marked decreases are 1988: 
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observed only in a more selected group of patients. 
These changes may be of potential functional impor- 
tance in the regulation of the immune response in a 
variety of clinical settings. 
Rheumatoid arthritis is a chronic, systemic inflammatory 
disorder of unknown etiology characterized by the manner 
in which it involves the joints. Unidentified initiating stimuli 
appear to cause an aberration within the immune system 
in genetically susceptible persons that may be self-per- 
petuating. There are multiple abnormalities of both hu- 
moral and cellular immunity in patients with rheumatoid 
arthritis, including circulating rheumatoid factors, hyper- 
gammaglobulinemia, cutaneous anergy, and increased 
numbers of circulating activated lymphocytes [l-4]. More 
marked changes are demonstrable in affected joints and 
in the inflamed synovium which, with its complex im- 
mune-cell infiltrate, appears like and in many respects 
can function as an ectopic lymphoid organ [3-61. The T 
cells found in synovial tissue and fluid are highly activated 
and differ in many respects from circulating T cells in 
patients with rheumatoid arthritis and in normal subjects 
[4,6-181. In earlier studies of patients with rheumatoid 
arthritis, abnormalities in CD4 (T4)/CD8 (T8) ratios of 
peripheral blood lymphocytes were modest and some- 
times difficult to demonstrate, while studies of synovial 
fluid and tissue lymphocytes have frequently shown a 
lower T4/T8 ratio than in peripheral blood, with only a 
slight excess of T4 over T8 cells [8-121. Moreover, 
lymphocytes from rheumatoid synovial fluid exhibit nu- 
merous abnormalities. They are reported to exhibit abnor- 
malities in the autologous mixed lymphocyte reaction 
(AMLR) [ 12- 141, are hyperactive in their responses to 
some mycobacterial and endogeneous antigen [ 15,161, 
deficient in suppressor function [ 12,17- 181, and, despite 
the presence of numerous, apparently activated cells with 
CD8-I cytotoxic/suppressor phenotype, are able to pro- 
vide or augment help in some experimental systems for B 
cell Ig production and for the activation of macrophages 
[ 12,17,19]. The cellular basis for these functional T-cell 
abnormalities is unknown, and it is unclear whether they 
occur primarily in rheumatoid arthritis, representing 
unique pathophysiologic mechanisms, or if they are of 
more general importance in other chronic immune-medi- 
ated rheumatic disease syndromes. 
a reciprocal population of T cells (T4+484-l-) that act to 
provide helper-inducer function [2 11. We have character- 
ized both peripheral blood lymphocytes and synovial fluid 
lymphocytes in patients with rheumatoid arthritis as well 
as other inflammatory joint diseases. The results showed 
that diminished proportions of T4+2H4+ cells and in- 
creased proportions of T4i-4B4-t cells are a common 
feature of T4 cells in synovial fluid in rheumatoid arthritis 
as well as a variety of other acute and chronic inflamma- 
tory disorders, whereas changes in peripheral blood lym- 
phocytes are seen in a more selected group of patients. 
PATIENTS AND METHODS 
Patients. Peripheral blood samples were obtained from 21 
patients with classical or definite rheumatoid arthritis ac- 
cording to the criteria of the American Rheumatism Associ- 
ation [26]. These included seven men and 14 women, with 
a mean age of 56 f 12 years (mean f SD), 37 patients with 
other articular diseases (16 men and 21 women with a 
mean age of 53 f 13 years), including osteoarthritis, 17; 
gout, four; HLA-B27-associated spondyloarthropathy (in- 
cluding ankylosing spondylitis and Reiter’s syndrome), 11; 
and psoriatic peripheral arthritis, five; and 33 healthy con- 
trol subjects (15 men and 18 women, mean age 40 f 15 
years). Peripheral blood lymphocytes were also obtained 
from one patient with progressive systemic sclerosis and 
two patients with primary Sjogren’s syndrome. 
We have recently developed the novel monoclonal 
antibodies anti-2H4 and anti-4B4, which can be used to 
subdivide human CD4 (T4) cells into distinct and largely 
reciprocal functional subsets [20,21]. The anti-2H4 anti- 
body defines a subset of T4 cells (T4+2H4+), previously 
described as the T4+JRA+ subset [22], that induces T8 
cells to exert suppressor function in both pokeweed mito- 
gen-driven IgG [20] and antigen-specific antibody produc- 
tion systems [23] and which maximally responds in the 
AMLR [24,25]. In contrast, the anti-4B4 antibody defines 
Synovial fluid samples were obtained from 12 patients 
with rheumatoid arthritis and six with other inflammatory 
joint diseases (gout, one; pseudogout, one; inflammatory 
bowel disease with peripheral arthritis, one; psoriatic arthri- 
tis, one: and Reiter’s syndrome, two). Peripheral blood 
lymphocytes were simultaneously obtained from six pa- 
tients with rheumatoid arthritis, two patients with Reiter’s 
syndrome, and one patient with gout. 
Isolation of Lymphocytes. Human mononuclear lympho- 
cytes from heparinized blood and synovial fluid were isolat- 
ed by Ficoll-Hypaque density gradient centrifugation (Phar- 
macia Fine Chemicals, Piscataway, New Jersey) as previ- 
ously described [ 12,201. 
Monoclonal Antibodies. Four monoclonal antibodies 
termed anti-CD4 (T4), anti-CD8 (T8), anti-2H4, and anti-4B4 
were used in the current study. Their production and char- 
acterization are described elsewhere [20,21,27]. Anti-T4, - 
T8, -2H4, and -4B4 are available through Coulter Immunolo- 
gy, Hialeah, Florida. 
Analysis of Lymphocyte Populations with Single and Two- 
Color Fluorescence Flow Cytometry. Single-color fluo- 
rescence flow cytometric analysis was performed on an 
Epics C cell sorter (Coulter Electronics, Inc.). Cells were 
stained with the monoclonal antibodies at a dilution of 1500 
followed by incubation with a F(ab’)n fragment of goat anti- 
mouse antibody conjugated to fluorescein isothiocyanate 
(FITC) (Tago Inc., Burlingame, California). Background fluo- 
rescence reactivity was .determined with control ascites 
fluid obtained from mice immunized with a non-secreting 
hybridoma. Two-color analysis was carried out on an Epics 
C cell sorter using a 488-nm argon laser, gating for lympho- 
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TABLE I Cell Surface Characteristics of Lymphocytes in Blood and Synovial Fluid in Patients with Rheumatoid 
Arthritis or Other Artlcular Diseases, and Normal Control Subjects* 
Sex Age 
Percent 
Disease Group WM) (years) 2H4 484 T4+2H4+ 14+484+ T4lTB 
Blood 
Normal controls (n = 33) 
Rheumatoid arthritis (n = 21) 
Osteoarthritis (n = 17) 
Gout (n = 4) 
B27-k spondyloarthropathy (n = 11) 
Psoriatic arthritis (n = 5) 
Synovial fluid 
16/15 40f 15 
1417 56f 12 
1314 62f 11 
014 57f 11 
316 37 f 13 
312 52 f 6 
Rheumatoid arthritis (n = 12) 1012 
Other (n = 6) 214 
Inflammatory joint diseases 
49f 13 
33f 11 





61 f 14 
22f 11+ 






48 f 8 
66 f 18+ 
77 f 97 
19.0 f 6 
15.5 f 8 
13.7 f 7+ 
14.3 f 7 
14.4 f 9, 
15.1 f 6 
3.1 f 1+ 
4.2 f 3+ 
23.0 f 7 
24.2 f 9 
26.7 f 7 
28.5 f 8 
22.3 f 9 
21.0 f 7 
29.1 f 95 
33.1 f 9t 
2.1 f 1.0 
2.4 f 1.0 
2.2 f 0.8 
2.3 f 0.7 
2.3 f 0.8 
2.0 f 1.2 
2.0 f 1.6 
ND 
ND = not determined. 
* Results are expressed as mean f SD. 
+ p <0.005 as compared with normal control subjects. 
t p <0.025 as compared with normal control subjects. 
* p <0.05 as compared with normal control subjects. 
‘* p <O.Ol as compared with normal control subjects. 
cyte populations, and utilizing FITC-anti-T4, 2HCphycoery- 
thrin (PE), and 4B4-PE. For each sample, 10,000 cells were 
analyzed on a log fluorescence scale as described previ- 
ously [28]. All analyses were performed without knowl- 
edge of patients’ clinical status, and after surface labeling 
with monoclonal antibodies, the cells were immediately 
applied to the flow cytometer without formaldehyde fixa- 
tion. 
Suppressor Function of Autologous Mixed Lymphocyte 
Reaction (AMLR)-Activated T Cells. Suppressor function 
of T4 cells from synovial fluid and peripheral blood in 
patients with rheumatoid arthritis upon activation during the 
AMLR was assessed by the addition of AMLR-activated T4 
cells to secondary cultures freshly prepared from a healthy 
single donor. AMLR cultures were prepared in RPM1 1640 
supplemented with 10 percent AB serum, 4 mM L-gluta- 
mine, 25 mM Hepes buffer (Microbiological Associates), 
0.5 percent sodium bicarbonate, and 1 percent penicillin- 
streptomycin. For primary AMLR cultures, 2 X IO6 respond- 
er T4 cells were co-cultured with 2 X lo6 irradiated (5,000 
rads) peripheral blood E- cells in 4 ml total volume of media 
in 25cm* culture flasks (Falcon, Oxnard, California). After 
seven days, cultured cells were layered over Ficoll-Hypa- 
que, centrifuged at 2,000 revolutions/minute for 20 min- 
utes, and then washed three times. For assessing suppres- 
sor-inducer function, 2 X lo4 AMLR-activated T4 cells were 
added to 1 X lo5 freshly isolated peripheral blood lympho- 
cytes from a healthy single donor in the presence of poke- 
weed mitogen (1: 100) and cultured in round-bottomed 96- 
well microculture plates in 200 kl/well of media with 20 
percent fetal calf serum for seven days as previously de- 
scribed [25]. IgG in culture supernatants was determined 
by radioimmunoassay. 
Statistical Methods. Results are expressed as mean f 
SD. Statistical analysis was performed using a two-tailed t 
test as indicated to calculate p values. 
RESULTS 
Cell surface antigens of lymphocyte populations from 
peripheral blood and synovial fluid in patients with rheu- 
matoid arthritis, patients with other joint diseases (osteo- 
arthritis, gout, 827-F spondyloatthropathy, and psoriatic 
arthritis), and healthy normal control subjects are summa- 
rized in Table I. There were no significant differences 
between normal controls, patients with rheumatoid arthri- 
tis, and patients with other joint diseases (osteoarthritis, 
gout, B27-F spondyloarthropathy, and psoriatic arthritis) in 
the percentage of 2H4-bearing and 4B4-bearing lympho- 
cytes, T4+484+ cells, or the T4/T8 ratio of peripheral 
blood lymphocytes. Although there were no significant 
differences between normal control subjects and patients 
with rheumatoid arthritis in the percentage of T4+2H4+ 
cells in peripheral blood lymphocytes, the percentage of 
T4+2H4+ suppressor-inducer cells in peripheral blood 
lymphocytes of patients with osteoarthritis (13.7 f 7) and 
gout (14.3 f 7) was decreased compared with the per- 
centage in our normal control group (19.0 f 6) (osteoar- 
thritis versus normals, p <0.025). When the normal 
control subjects were arbitrarily divided into younger (less 
than 50 years old) and older (50 years old or older) 
groups, it was found that the older group had a somewhat 
lower mean value for T4+2H4+ peripheral blood T cells, 
(14.5 f 6 percent) compared with (20.5 f 6 percent), 
respectively. The values for the patients with osteoarthri- 
tis and gout (with mean ages of 62 and 57 years, respec- 
tively) did not differ from those of the older control sub- 
jects. Taken together, these data suggest an age-associ- 
ated rather than disease-associated decrease in this 
T-cell population. 
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w 
A. B. 
2H4 vs CD4 4B4 vs CD4 
In contrast to peripheral blood lymphocytes, synovial 
fluid lymphocytes exhibited substantial differences in ex- 
pression of these cell surface antigens. For example, 
patients with rheumatoid arthritis as well as other inflam- 
matory joint diseases had a marked decrease in total 2H4- 
bearing cells (22 f 11 percent and 25 f 22 percent, 
respectively) and T4+2H4+ suppressor-inducer cells 
(3.1 f 1 percent and 4.2 f 3 percent, respectively) as 
compared with the proportions found in peripheral blood 
lymphocytes. Furthermore, there was a significantly in- 
creased percentage of 4Bbbearing cells (66 f 18 per- 
cent and 77 f 9 percent, respectively) and T4+4B4+ 
helper cells (29.1 f 9 percent and 33.1 f 9 percent, 
respectively) in synovial fluid as compared with peripheral 
blood lymphocytes. 
Figure 1 shows representative two-color profiles of 
peripheral blood lymphocytes and synovial fluid lympho- 
cytes co-expressing either T4 and 2H4 or T4 and 4B4 
antigens in a patient with rheumatoid arthritis. These 
analyses were done using anti-T4 conjugated to FITC and 
anti-2H4 and anti-4B4 conjugated to PE. Log green fluo- 
rescence (the T4 subset) is shown along the Y axis and 
log red fluorescence (the 2H4 subset, A, or the 484 
subset, B) is shown along the X axis. Cell number is 
represented by the height of the curve. T4+2H4+ or 
T4+4B4+ double-positive cells are shown as cell clus- 
Figure 1. Profile of peripheral blood 
lymphocytes (I) and synovial fluid Iym- 
phocytes (/I) co-expressing either CD4 
(T4) and 2H4 or CD4 (T4) and 484 anti- 
gens in a patient with rheumatoid arthri- 
tis. These analyses were done using 
anti-T4 conjugated to FITC and anti-2H4 
and anti-4B4 conjugated to PE. 
ters in the center of each panel. In this representative 
example, 2 1.1 percent of cells are T4+2H4+ (suppres- 
sor-inducer) and 23.4 percent of cells are T4-t4B4-F 
(helper-inducer) among peripheral blood lymphocytes, 
but only 3.1 percent of cells are T4+2H4+ and 29.4 
percent of cells are T4+4B4+ in the synovial fluid of this 
patient. Figure 2 shows the percentages of T4+2H4+ 
cells in peripheral blood and synovial fluid in all groups 
studied. 
Since a value of less than 7 percent represents 2 SD 
below the mean percentage of T4+2H4+ cells in the 
peripheral blood of normal control subjects, values below 
7 percent were considered to be significantly lower than 
normal. As shown in Figure 2, only one of 2 1 patients with 
rheumatoid arthritis had significantly decreased numbers 
of T4+2H4+ cells in peripheral blood lymphocytes. This 
patient, although lacking any clinically significant synovi- 
tis, had Felty’s syndrome with associated splenomegaly 
and marked granulocytopenia. The number of T4+2H4-l- 
cells in the peripheral blood lymphocytes of all patients 
with rheumatoid arthritis without associated disease was 
within the normal range. These values were not found to 
correlate with either disease activity or medication (data 
not shown). Moreover, all patients studied with osteoar- 
thritis, gout, and psoriatic arthritis had normal percentages 
of T4+2H4+ peripheral blood lymphocytes. Unexpect- 
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lll&i-lIILu day9 
uuu day 7 
uu, day 4 
14-u day 2 
u]II, day 0 
404 2H4 IL-2 Receptor 
Expression Expression Expression 
sought to examine whether in vitro activation of T cells 
might produce alterations in the surface expression of 
2H4 similar to those we had observed in vivo. The expres- 
sion of 2H4 and 4B4 was examined over a nine-day 
period following activation by the mitogen phytohemag- 
glutinin. T4 cells from a normal donor were activated with 
phytohemagglutinin (0.25 pg/ml) for four days, after 
which the culture medium was replaced every two days 
with medium containing 10 percent T-cell growth factor 
and 10 percent human serum. As shown in Figure 4, at 
the initiation of culture (Day 0), 2H4 was detected on 51 
percent of these cells. On Day 4, the percentage of cells 
expressing 2H4 was starting to decrease. By this time, the 
percentage of cells expressing 484 and the density of 
484 expression were both increased. Notably, a dimin- 
ished number of T4+2H4+ cells were present on Day 7 
(23 percent) and Day 9 (21 percent), along with de- 
creased levels of 2H4 antigen on the 2H4-I cells present. 
IL2 receptor expression was examined in parallel. IL2 
receptor expression was minimal on Day 2 but gradually 
increased. By Days 7 and 9, IL2 receptors were ex- 
pressed on approximately 60 percent of the phytohemag- 
glutinin-activated T4 cells. As in the representative exper- 
iment shown, in most experiments activation of T cells 
with phytohemagglutinin or concanavalin A ultimately re- 
sulted in a gradual decrease in 2H4 antigen expression 
and increased 4B4 antigen expression. In some donors, 
however, the 2H4 antigen was stably expressed on con- 
canavalin A- or phytohemagglutinin-activated T cells for 
up to 2 1 days of culture (data not shown). 
These studies suggest that in vivo T-cell activation may 
be responsible for diminished 2H4 expression and the 
decreased numbers of T4+2H4+ cells observed. Further 
studies, however, will be required to determine the rela- 
tive contributions of diminished 2H4 antigen expression 
on T4+ cells that are initially 2H4+ and the possibility that 
these data might instead reflect a selective growth advan- 
tage of T4+4B4+ cells over T4+2H4+ cells under long- 
term culture conditions or with chronic in vivo stimulation. 
These two possibilities are not mutually exclusive. 
Figure 4. 2H4, 4B4, and IL-2 receptor 
expression on phytohemagglutinin-acti- 
vated T4 cells. T4 cells from a normal 
donor were activated with phytohemag 
glutinin (0.25 pg/mf) in the presence of 5 
percent macrophages for the indicated 
number of days. Subsequently, the cells 
were washed four times and were 
stained with monoclonal antibodies and 
fluorescein-conjugated F(ab’)*, and cyte 
fluorographic analysis was performed by 
indirect immunofluorescence on an Ep- 
ics C cell sorter. Cells ( 10,000) were 
analyzed on a log fluorescence scale. 
To determine whether the decreased percentage of 
T4+2H4+ suppressor-inducer cells in synovial fluid was 
associated with a corresponding functional defect, we 
utilized a well-defined functional assay system for detec- 
tion of suppressor-inducer activity [25]. The co-culture of 
CD4i- T cells activated during an AMLR with fresh poke- 
weed mitogen-stimulated peripheral blood lymphocytes 
will induce the CD8-I T cells present in the second culture 
to suppress B cell lg secretion in that culture. We there- 
fore examined the suppressor-inducer activity of AMLR- 
activated T4 cells from both peripheral blood and synovial 
fluid in patients with rheumatoid arthritis and of AMLR- 
activated T4 cells from peripheral blood of normal con- 
trols. For this purpose, peripheral blood T4 cells from a 
normal donor and T4 cells from both peripheral blood and 
synovial fluid in patients with rheumatoid arthritis were 
stimulated for seven days with autologous peripheral 
blood non-T cells, then these AMLR-activated T4 cells (2 
X 104) were added to 1 X lo5 freshly isolated peripheral 
blood lymphocytes from a healthy single donor to assess 
their effect on pokeweed mitogen-driven IgG synthesis. 
As shown in Table II, experiments 1 and 2, both AMLR- 
activated T4 cells from a normal donor and AMLR-activat- 
ed T4 cells from peripheral blood of patients with rheuma- 
toid arthritis exhibited a strong suppressor activity. In 
sharp contrast, AMLR-activated T4 cells from the synovial 
fluid of the same patients had minimal or no suppressor 
activity. Thus, not only was the suppressor-inducer subset 
quantitatively diminished in rheumatoid arthritic synovial 
fluid by phenotypic criteria, but suppressor-inducer activi- 
ty of T4 cells was correspondingly diminished by function- 
al assay as well. Due to difficulties in obtaining concurrent 
synovial fluid and peripheral blood lymphocyte samples, 
only two independent analyses of both phenotypic and 
functional parameters could be performed. 
COMMENTS 
The current study utilizes the anti-2H4 and anti-4B4 mon- 
oclonal antibodies to characterize the cell surface pheno- 
type of lymphocytes in peripheral blood and synovial fluid 
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of patients with rheumatoid arthritis and other joint dis- 
eases. We found that in the synovial fluid, patients with 
rheumatoid arthritis had a selectively decreased percent- 
age of T4+2H4+ suppressor-inducer cells and signifi- 
cantly increased percentage of T4-t484-I helper-inducer 
cells as compared with the proportions found in peripheral 
blood. Moreover, patients with other chronic and acute 
inflammatory joint diseases exhibited highly similar find- 
ings. In contrast, in the peripheral blood, most patients 
with rheumatoid arthritis and other joint diseases had a 
normal percentage of T4+2H4+ and T4+4B4+ cells 
compared with the percentage in normal control subjects. 
Interestingly, one patient with rheumatoid arthritis and 
Felty’s syndrome, two patients with primary Sjogren’s 
syndrome, one patient with progressive systemic sclero- 
sis, and five of seven patients with Reiter’s syndrome had 
significantly decreased percentages of T4+2H4+ cells in 
the peripheral blood. The basis for the abnormalities in 
these patients is currently unclear, but might relate to the 
systemic nature of these syndromes. These observations 
will require further examination, including evaluation of a 
much larger number of patients, as well as serial studies. 
In addition, our current and previous findings also suggest 
that there are age-related changes in the proportions of 
these cell populations, unrelated to inflammatory disease. 
We had previously reported that patients with chronic 
progressive multiple sclerosis and patients with active 
systemic lupus erythematosus (particularly those patients 
with active renal disease) had a selective decrease in the 
number of T4+2H4+ suppressor-inducer cells in the 
peripheral blood [28,29]. Of the patients with rheumatoid 
arthritis, only the patient with Felty’s syndrome had a 
significantly decreased number of T4+2H4+ cells in her 
blood. In this regard, two groups have reported that a 
defect of suppressor T-cell function is present in patients 
with early active rheumatoid arthritis (duration of active 
disease less than three months) but not in patients with 
chronic active rheumatoid arthritis (duration of active dis- 
ease more than six to 12 months) [30,3 11. Since all of our 
patients with rheumatoid arthritis studied had clearly es- 
tablished disease with a duration of at least three months, 
it is possible that some patients with very early disease 
might exhibit a suppressor cell defect that we did not 
detect in our system in this study. Further longitudinal 
study including early patients with possible rheumatoid 
arthritis will be required to clarify these points. 
It has been shown that the T4+2H4+ subset of cells 
proliferates maximally in response to autologous non-T 
cells but poorly to soluble antigen stimulation [20,25], 
thus explaining in part our prior observations that predom- 
inantly suppressor signals, rather than help for Ig secre- 
tion, were generated during the AMLR in the absence of 
foreign antigen [32]. Moreover, T4+2H4+ cells are re- 
sponsible for the inducer of suppressor function similar to 
that previously described for the T4+JRA+ subset, by 
which T8-l- cells are induced or activated to exert sup- 
TABLE II Suppressor-Inducer Function of AMLR T4 
Cells from Peripheral Blood Lymphocytes 
and Synovial Fluid in Patients with 
Rheumatoid Arthritis* 
Experiment 1 Experiment 2 
- 8,660 f 310 7,140 f 220 
AMLR T4n 3,850 f 260 (56) 2,930 f 170 (59) 
AMLR RA T4ps 3,970 f 180 (54) 3,050 f 150 (57) 
AMLR RA T4sr 8,010 f 270 (8) 7,560 f 110 (-5) 
* T4N = peripheral blood T4 cells from a normal donor; T4ps = 
peripheral blood T4 cells from a patient with rheumatoid arthritis; 
T4sF = synovial fluid T4 cells from a patient with rheumatoid 
arthritis. 
AMLR-activated T4 cells (2 X 104) were added to 1 X lo5 freshly 
isolated peripheral blood lymphocytes from a normal donor with 
pokeweed mitogen to assess their immunoregulatory role. Results 
were expressed as mean of triplicate samples f SD. Percent 
suppression, shown in parentheses, was calculated as follows: 
[ ( 
, _ observed IgG in the presence of regulatory cells 11 x 100 IgG secretion in the absence of regulatory cells 
pressor-effector function [20]. More importantly, our data 
also suggest that the 2H4 molecule itself may be involved 
in generating suppressor signals [25]. In contrast, the 
T4+484+ subset of cells provides helper function in both 
pokeweed mitogen-stimulated IgG synthesis and antigen- 
specific antibody production assays [2 1,231. Fut-ther- 
more, T4+4B4+ cells, like T4fJRA- cells, proliferate 
well to soluble antigen stimulation but relatively poorly to 
autologous non-T cells [2 1,241. 
The results demonstrating the scarcity of T4-t2H4-t 
cells and substantial numbers of T4+4B4+ cells in syno- 
vial fluid in rheumatoid arthritis clarify in part some of the 
previously reported findings on synovial fluid lymphocyte 
function including the observation that synovial fluid lym- 
phocytes respond poorly in the AMLR, although they may 
respond well to selected soluble antigens, and lack sup- 
pressor activity [ 12,13,15-l 71. Moreover, the abun- 
dance of T4+4B4+ cells may explain the abundant pro- 
duction of immunoglobulin, including rheumatoid factors, 
and it is possible to speculate that the production of 
various lymphokines and other inflammatory mediators in 
the rheumatoid arthritic joint is promoted through related 
“helper” circuits. The findings of profound phenotypic 
and functional abnormalities in the synovial compartment 
as compared with minimally abnormal or normal findings 
in the peripheral blood are consistent with the previous 
observations of numerous investigators [l-18]. Two re- 
ports published since the completion of these studies also 
demonstrate in synovial fluid of patients with rheumatoid 
arthritis an increase in helper cells for antibody production 
and a decrease in the subpopulation containing suppres- 
sor-inducer cells [33,34]. One of these used a different 
panel of monoclonal antibodies, which we have previous- 
ly shown [20] recognize different cell subpopulations than 
our reagents, and was limited to patients with rheumatoid 
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arthritis, healthy normal control subjects, and several 
patients with osteoarthritis [33]. The other study [34], 
which did use the monoclonal antibodies we developed, 
also was limited primarily to patients with rheumatoid 
arthritis, healthy control subjects, and patients with non- 
inflammatory arthritis (11 of 13 patients with other articu- 
lar diseases studied). Several important points made by 
our study substantially extend these observations. First, 
the scarcity of T4+2H4+ cells and increased numbers of 
T4+4B4+ cells in the synovial fluid are not limited to the 
synovial fluid of patients with rheumatoid arthritis. Similar 
findings are also observed in synovial fluid of patients with 
inflammatory joint diseases including not only the serone- 
gative arthropathies but also crystal-induced acute joint 
inflammation. Thus, these changes do not represent a 
pathologic change unique to rheumatoid arthritis or even 
chronic inflammatory joint disease, but occur as part of a 
more generalized phenomenon. Second, patients with 
disorders that may have a more systemic or diffuse in- 
flammatory component (Reiter’s, Sjogren’s, scleroder- 
ma, rheumatoid arthritis with Felty’s) can exhibit such 
alterations in their peripheral blood, in contrast to most 
patients with rheumatoid arthritis. Third, we have shown 
that these phenotypic changes have functional implica- 
tions by use of in vitro assays that may reflect and explain 
some of the previously described observations made with 
rheumatoid arthritis synovial T cells. Finally, we have 
demonstrated in a preliminary fashion that a diminution in 
this important regulatory population of T4+2H4+ sup- 
pressor-inducer cells may occur in association with in- 
creased age. 
The mechanisms responsible for the paucity of 
T4+2H4+ cells and the increased representation of 
T4+484+ cells are not clear at this time and may differ in 
the various disorders. One principal possibility is that 
synovial T cells may already be in an intensely activated 
state, as suggested by their considerably elevated expres- 
sion of la and other activation antigens. Because the 4B4 
antigen is expressed on both resting and activated T4 
cells, while 2H4 antigen density eventually decreases 
after cell activation and is often eventually lost from 
activated cells [35, 36, and this study], the relative excess 
of 4B4-l- cells in the joint may reflect, at least in part, their 
activation state. Thus, in conditions where lymphocytes 
are intensely activated such as synovial fluid, there may 
be more 4B4+ T cells and less 2H4-t T cells. In addition, 
our earlier studies showed that the density and expression 
of the 2H4 antigen were strongly correlated with suppres- 
sor-inducer function in both AMLR and concanavalin A 
systems [35,36]. Alternative mechanisms for this con- 
centration of T4-!-4B4+ cells might be an increased 
responsiveness of these cells to chemoattractants pre- 
sent in inflammatory joint effusions or differential entry of 
particular subsets of T4 cells into the joint. With respect to 
the latter, Jalkanen et al [37] have shown that the specific 
receptors for T-cell adherence to synovial endothelial 
cells differ from those for adherence to mucosal or lymph 
node endothelial cells. Thus, particular T cell subsets may 
be programmed to enter the synovium. The consequent 
lack of T4+2H4+ cells might therefore be due to their 
relative inability to adhere to the endothelial cells of syno- 
vial blood vessels, whereas T4+4B4+ cells may repre- 
sent the subset programmed to enter the joint. 
In this regard, recent studies from our group have 
shown that the 4B4 molecule is comprised of 135-, 160-, 
and 185-kilodalton glycoproteins and belongs to a family 
of cell adhesion molecules that includes the fibronectin 
receptor and related structures [38]. Further studies are 
now in progress to determine whether T4+4B4+ cells 
preferentially adhere to the endothelial cells of the syno- 
vium. If this is the case, then in the presence of a variety 
of immunologic stimuli, there could be ongoing immuno- 
logic reactivity due to a lack of capacity for induction of 
suppression in association with an abundance of helper 
cells. This could promote the formation of immune com- 
plexes and the release of lymphokines and other inflam- 
matory mediators as secondary and tertiary events in the 
evolution of rheumatoid as well as other forms of inflam- 
matory synovitis. The mechanisms by which such a re- 
sponse is regulated are at this time unknown. 
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